These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2687768)
1. Nucleotide sequence analysis of human abl and bcr-abl cDNAs. Fainstein E; Einat M; Gokkel E; Marcelle C; Croce CM; Gale RP; Canaani E Oncogene; 1989 Dec; 4(12):1477-81. PubMed ID: 2687768 [TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase. Oda T; Kujovich J; Reis M; Newman B; Druker BJ Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092 [TBL] [Abstract][Full Text] [Related]
3. Cloning and sequencing of the human c-abl 3' untranslated region. Andrews DF; Tompkins CK; Hendrickson SL; Singer JW Oncogene; 1990 Mar; 5(3):441-4. PubMed ID: 2179820 [TBL] [Abstract][Full Text] [Related]
4. Four murine c-abl mRNAs arise by usage of two transcriptional promoters and alternative splicing. Bernards A; Paskind M; Baltimore D Oncogene; 1988 Apr; 2(4):297-304. PubMed ID: 3283651 [TBL] [Abstract][Full Text] [Related]
5. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. Perrotti D; Bonatti S; Trotta R; Martinez R; Skorski T; Salomoni P; Grassilli E; Lozzo RV; Cooper DR; Calabretta B EMBO J; 1998 Aug; 17(15):4442-55. PubMed ID: 9687511 [TBL] [Abstract][Full Text] [Related]
6. Nucleotide sequence of the rat Bmyc gene. Asker C; Steinitz M; Andersson K; Sümegi J; Klein G; Ingvarsson S Oncogene; 1989 Dec; 4(12):1523-7. PubMed ID: 2687773 [TBL] [Abstract][Full Text] [Related]
7. Fusion of the bcr and the c-abl genes in Ph'-positive acute lymphocytic leukemia with no rearrangement in the breakpoint cluster region. ar-Rushdi A; Negrini M; Kurzrock R; Huebner K; Croce CM Oncogene; 1988 Apr; 2(4):353-7. PubMed ID: 3283653 [TBL] [Abstract][Full Text] [Related]
8. DNA sequence analysis of an abl-related gene in the blow fly, Calliphora erythrocephala. Durica DS; Robinson CE; Voelker RB SAAS Bull Biochem Biotechnol; 1990 Jan; 3():58-62. PubMed ID: 1367423 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Hantschel O; Superti-Furga G Nat Rev Mol Cell Biol; 2004 Jan; 5(1):33-44. PubMed ID: 14708008 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover. Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551 [TBL] [Abstract][Full Text] [Related]
11. Suppression of bcr-abl synthesis by siRNAs or tyrosine kinase activity by Glivec alters different oncogenes, apoptotic/antiapoptotic genes and cell proliferation factors (microarray study). Zhelev Z; Bakalova R; Ohba H; Ewis A; Ishikawa M; Shinohara Y; Baba Y FEBS Lett; 2004 Jul; 570(1-3):195-204. PubMed ID: 15251464 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of bcr-abl and/or c-abl gene expression by small interfering, double-stranded RNAs: cross-talk with cell proliferation factors and other oncogenes. Ohba H; Zhelev Z; Bakalova R; Ewis A; Omori T; Ishikawa M; Shinohara Y; Baba Y Cancer; 2004 Sep; 101(6):1390-403. PubMed ID: 15368327 [TBL] [Abstract][Full Text] [Related]
13. Sequences within the first exon of BCR inhibit the activated tyrosine kinases of c-Abl and the Bcr-Abl oncoprotein. Liu J; Wu Y; Arlinghaus RB Cancer Res; 1996 Nov; 56(22):5120-4. PubMed ID: 8912843 [TBL] [Abstract][Full Text] [Related]
14. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase. Ren SY; Xue F; Feng J; Skorski T Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545 [TBL] [Abstract][Full Text] [Related]
15. A novel Yes-related kinase, Yrk, is expressed at elevated levels in neural and hematopoietic tissues. Sudol M; Greulich H; Newman L; Sarkar A; Sukegawa J; Yamamoto T Oncogene; 1993 Apr; 8(4):823-31. PubMed ID: 8455940 [TBL] [Abstract][Full Text] [Related]
16. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress. Velasco JA; Avila MA; Notario V Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819 [TBL] [Abstract][Full Text] [Related]
17. Isolation and structural analysis of a biologically active chicken c-fos cDNA: identification of evolutionarily conserved domains in fos protein. Mölders H; Jenuwein T; Adamkiewicz J; Müller R Oncogene; 1987; 1(4):377-85. PubMed ID: 3330781 [TBL] [Abstract][Full Text] [Related]
18. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes]. Zhang DL; Ji L; Li YD Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601 [TBL] [Abstract][Full Text] [Related]
19. The human met oncogene is a member of the tyrosine kinase family. Gonzatti-Haces M; Park M; Dean M; Blair DG; Vande Woude GF Princess Takamatsu Symp; 1986; 17():221-32. PubMed ID: 3332011 [TBL] [Abstract][Full Text] [Related]
20. Use of a temperature-sensitive mutant to define the biological effects of the p210BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line. Carlesso N; Griffin JD; Druker BJ Oncogene; 1994 Jan; 9(1):149-56. PubMed ID: 8302574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]